For the diabetes patients receiving long-acting sulfonylureas drugs (such as Gliclazide Sustained-release Tablets and Glimepiride Tablets), premixed insulin and medium-acting or long-acting insulin, special attention should be paid to the influence of Somogyi effect.
Ezigulini ezinesifo sikashukela ezithola izidakamizwa ezisebenza nge-sulfonylureas ezisebenza isikhathi eside (ezinjenge-Gliclazide Sustained-release Tablets kanye ne-Glimepiride Tablets), i-insulin eqashelwe kanye ne-insulin esebenza kanye noma i-insulin esebenza isikhathi eside, kufanele kubhekwe ngokukhethekile umthelela womphumela we-Somogyi.